Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

JBT Marel Corporation (JBTM) SEC Filings & Earnings Calls

EquiReason read 12 JBT Marel Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-08-05 — JBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

JBTMJBT Marel CorporationFollow JBTM — free
Specialty Industrial Machinery · Industrials
—
Price chart with a free account
Market cap
5.6B
P/E TTM
29.5
Dividend yield
0.4%
52-week
—
Next earnings
3 Nov, in 10 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

5 Aug 202610-QJBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$981M+5% y/y
Net income · Q2-2026$28M+833% y/y
Backlog · 2026-06-30$1.50B

Risks flagged

Integration risk from Marel acquisition

“The impairment charge resulted from updated business forecasts for the affected operation.”

High leverage

“Total debt, including current portion $1,679 million as of June 30, 2026.”
Read the original on SEC EDGAR ↗
3 Aug 20268-K · 2.02Q2 2026 revenue $981M (+5% YoY), orders $1.03B (book-to-bill 1.05x), backlog $1.54B; adj. EBITDA margin 17.1% (+40bps); FY guidance reiterated; $200M buyback authorized.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$981M+5% y/y
Net income · Q2-2026$28M
Net income margin · Q2-20262.9%
Adjusted EBITDA · Q2-2026$168M
Adjusted EBITDA margin · Q2-202617.1%
Diluted EPS · Q2-2026$0.54
Adjusted EPS · Q2-2026$1.95
Orders · Q2-2026$1.03B
Backlog · Q2-2026$1.54B
Operating cash flow · H1-2026$221M

Guidance

FY26 revenue $3,990-$4,065M; adj. EBITDA margin 17.0%-17.5%; adj. EPS $7.85-$8.35; GAAP EPS $4.20-$4.70; net income margin 5.5%-6.0%

FY2026 revenue and adj. EBITDA margin guidance reiterated; adj. EPS refined; strong demand and record backlog support H2 outlook.

Risks flagged

Operational inefficiencies and logistics constraints in Prepared Food and Beverage Solutions segment may persist.

“we experienced some operational inefficiencies and logistics constraints in the Prepared Food and Beverage Solutions segment in the second quarter” · word for word

Higher inflationary costs create near-term headwinds.

“we are navigating a dynamic operating environment with higher inflationary costs.” · word for word

Non-cash impairment charge of $33M indicates potential overpayment for prior acquisition.

“a $33 million non-cash, non-recurring impairment charge related to a 2021 acquisition.” · word for word
Read the original on SEC EDGAR ↗
14 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportSEC ↗
6 May 202610-QRevenue $936M; Net Income $45M; Backlog $1.50Bopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$936M
Net Income · Q1-2026$45M
Backlog · 2026-03-31$1.50B
Diluted EPS · Q1-2026$0.86

Guidance

Backlog of $1.5B provides revenue visibility; NextGen strategy targets organic growth and margin expansion; no specific numeric guidance provided.

Risks flagged

High Debt Levels from Acquisition

“Total debt, including current portion $1,843 million; $403 million convertible notes due May 2026.”

Integration Risk from Marel Acquisition

“Acquisition-related transaction costs totaling $64 million were recorded as Selling, general and administrative expense during the three months ended March 31, 2025.”

Foreign Exchange Exposure

“The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates.” · word for word
Read the original on SEC EDGAR ↗
4 May 20268-K · 2.02Revenue $936M (+10% y/y); Orders $1.07B; Backlog $1.49B; Guidance: Revenue $3.99-$4.065B, adjusted EBITDA margin 17.0%-17.5%, adjusted EPS $8.00-$8.50earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$936M+10% y/y
Orders · Q1-2026$1.07B
Backlog · Q1-2026$1.49B
Net income · Q1-2026$45M
Adjusted EBITDA · Q1-2026$142M
Adjusted EBITDA margin · Q1-202615.2%
GAAP diluted EPS · Q1-2026$0.86
Adjusted EPS · Q1-2026$1.58
Operating cash flow · Q1-2026$119M
Free cash flow · Q1-2026$100M

Guidance

Revenue $3.99-$4.065B, adjusted EBITDA margin 17.0%-17.5%, adjusted EPS $8.00-$8.50

Reiterated FY2026 guidance with strong Q1 demand and margin expansion trajectory.

Risks flagged

Tariff cost pressure on Prepared Food & Beverage segment margin.

“Segment adjusted EBITDA margin declined 170 basis points, which was impacted, as expected, by higher tariff costs” · word for word

CPG end market softness affecting Prepared Food & Beverage volume.

“lower volume from the CPG end market” · word for word

Operational challenges in warehouse automation business.

“operational challenges in the warehouse automation business” · word for word
Read the original on SEC EDGAR ↗
1 Apr 2026DEF 14AAnnual proxy statement filed for 2026 annual meeting, detailing executive compensation and governance.open

Figures in the filing · each found in the filing text

Total revenue · FY2025$3.80B+121% y/y
Income from continuing operations · FY2025$-50M
Adjusted EBITDA from continuing operations · FY2025$600M+104% y/y
Adjusted diluted earnings per share from net income · FY2025$6.41+4% y/y
Financial Leverage Ratio · FY2025$2.90
Adjusted EBITDA Margin · FY202515.8%

Risks flagged

Tariff Environment Uncertainty

“all while facing a constantly evolving tariff environment” · word for word

Integration Risk

“Our integration efforts focused on the customer value proposition.” · word for word

Pension Settlement Costs

“Recognition of non-cash pension plan related settlement costs 146.9 23.3 —” · word for word
Read the original on SEC EDGAR ↗
26 Mar 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportSEC ↗
2 Mar 202610-KRecurring revenue as % of total revenue 50open

Figures in the filing · each found in the filing text

Recurring revenue as % of total revenue · FY202550.0%

Risks flagged

Integration Risk from Marel Acquisition

“During the fourth quarter of 2025, we realigned our reportable segments to better reflect the integration of our new operating model.” · word for word

Fixed-Price Contract Risk

“Under such contracts, we are typically responsible for cost overruns. Our actual costs and any gross profit realized on these fixed-price contracts may vary from our estimates on which the pricing for such contracts was based.” · word for word

Supply Chain and Raw Material Cost Risk

“Increases in commodity prices resulting in increased manufacturing costs, such as petroleum-based products, metals or other raw materials we use in significant quantities.” · word for word
Read the original on SEC EDGAR ↗
23 Feb 20268-K · 2.02Revenue $3.80B; Adjusted EBITDA $600M; Adjusted EBITDA margin 15.8; Guidance: 2026 revenue guidance $3.99B-$4.065B; adjusted EBITDA margin 17.0%-17.5%earningsopen

Figures in the filing · each found in the filing text

Revenue · FY2025$3.80B
Adjusted EBITDA · FY2025$600M
Adjusted EBITDA margin · FY202515.8%
Orders · FY2025$3.80B
Backlog · Q4-2025$1.40B
Free cash flow · FY2025$250M
Operating cash flow · FY2025$342M
Protein Solutions segment revenue · Protein Solutions · FY2025$1.72B
Prepared Food and Beverage Solutions segment revenue · Prepared Food and Beverage Solutions · FY2025$2.08B
Adjusted EPS · FY2025$6.41

Guidance

2026 revenue guidance $3.99B-$4.065B; adjusted EBITDA margin 17.0%-17.5%

2026 guidance reflects continued growth in revenue, margins, and earnings; synergy savings expected.

Risks flagged

Tariff environment remains a challenge; integration risks from Marel acquisition.

“challenging tariff environment... M&A related costs of $115 million”
Read the original on SEC EDGAR ↗
18 Feb 20268-K · 7.01Segment Adjusted EBITDA - Protein Solutions Q1 2025 $62M; Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q1 2025 $78M; Segment Adjusted EBITDA - Protein Solutions Q2 2025 $86Mopen

Figures in the filing · each found in the filing text

Segment Adjusted EBITDA - Protein Solutions Q1 2025 · Protein Solutions · Q1-2025$63M
Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q1 2025 · Prepared Food and Beverage Solutions · Q1-2025$78M
Segment Adjusted EBITDA - Protein Solutions Q2 2025 · Protein Solutions · Q2-2025$86M
Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q2 2025 · Prepared Food and Beverage Solutions · Q2-2025$94M
Segment Adjusted EBITDA - Protein Solutions Q3 2025 · Protein Solutions · Q3-2025$94M
Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q3 2025 · Prepared Food and Beverage Solutions · Q3-2025$102M

Risks flagged

Integration risk from Marel acquisition; restructuring costs incurred.

“Restructuring related costs of $10.6M (Q1), $5.6M (Q2), $7.4M (Q3); M&A related costs of $74.4M (Q1), $20.0M (Q2), $5.8M (Q3).”
Read the original on SEC EDGAR ↗
4 Nov 202510-QQ3 2025 revenue exceeded expectations, but JBT segment margins declined due to tariffs; Marel acquisition contributed significantly.earningsopen

Figures in the filing · each found in the filing text

Revenue · Total · Q3-2025$1.00B+121% y/y
Adjusted EBITDA from continuing operations · Total · Q3-2025$171M+109% y/y
Adjusted EBITDA margin from continuing operations · Total · Q3-202517.1%
JBT segment Adjusted EBITDA · JBT · Q3-2025$71M-13% y/y
JBT segment Adjusted EBITDA margin · JBT · Q3-202515.3%
Marel segment Adjusted EBITDA · Marel · Q3-2025$100M
Marel segment Adjusted EBITDA margin · Marel · Q3-202518.6%
Adjusted diluted earnings per share from continuing operations · Q3-2025$1.94+10% y/y
Free cash flow · 9M-2025$163M+106% y/y

Guidance

2025 capex $90M-$95M; restructuring savings target $50M-$60M; tariff impacts expected

Revenue exceeded expectations, but tariff headwinds and margin pressure acknowledged. Mitigation actions underway.

Risks flagged

Tariff cost pressure on margins

“The decrease of $10.4 million or 12.7% was primarily driven by a decrease in gross profit from tariff impacts, unfavorable mix, and project variances.” · word for word

Integration execution risk

“the inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally or otherwise” · word for word

High leverage from Marel acquisition

“Interest expense increased $20.6 million compared to same period last year. The increase was driven by a higher average debt balance as well as higher interest rates on additional borrowings to fund the Marel Transaction” · word for word
Read the original on SEC EDGAR ↗
3 Nov 20258-K · 2.02Revenue $1.00B; Orders $946M; Backlog $1.30B; Guidance: FY2025 revenue guidance raised to $3.76B-$3.79B; adjusted EBITDA margin 15.75%-16.0%; adjusted EPS $6.10-$6.40earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$1.00B
Orders · Q3-2025$946M
Backlog · Q3-2025$1.30B
Income from Continuing Operations · Q3-2025$67M
Adjusted EBITDA · Q3-2025$171M
Adjusted EBITDA Margin · Q3-202517.1%
Diluted EPS · Q3-2025$1.28
Adjusted EPS · Q3-2025$1.94
Operating Cash Flow (YTD) · 9M-2025$224M
Free Cash Flow (YTD) · 9M-2025$163M

Guidance

FY2025 revenue guidance raised to $3.76B-$3.79B; adjusted EBITDA margin 15.75%-16.0%; adjusted EPS $6.10-$6.40

Raised guidance on strong Q3 performance, synergy savings, and operational productivity.

Risks flagged

Restructuring and M&A costs continue; $7M restructuring and $6M M&A costs in Q3.

“third quarter 2025 ... $7 million in restructuring related costs, and $6 million in M&A related costs”
Read the original on SEC EDGAR ↗

JBT Marel Corporation — questions

What did JBT Marel Corporation file recently?
12 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-05 — JBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions.

Every figure on this page comes from JBT Marel Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.